ResearcherMichael E. DeBakey VA Medical CenterNo recent work listed

Avo Artinyan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0353-4094; OpenAlex author ID A5013145077. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2011: 1 paper

Papers 1

Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma. Co-author DOI 10.1002/cncr.25763 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shaun P. McKenzie · 1 shared paper, 2011 · strength 0.03
- Paper Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma. DOI 10.1002/cncr.25763 ↗
Daniel A. Anaya · 1 shared paper, 2011 · strength 0.03
- Paper Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma. DOI 10.1002/cncr.25763 ↗
Joseph Kim · 1 shared paper, 2011 · strength 0.03
- Paper Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma. DOI 10.1002/cncr.25763 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.